U.S., Oct. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07205718) titled 'A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors' on Sept. 26.
Brief Summary: TAK-188 is a new medicine that targets a protein called CCR8, which is found on the surface of certain cells (Tregs) inside tumors. These cells can weaken the body's ability to fight cancer. TAK-188 may help to remove these Tregs. Removing these Tregs may allow more cancer-fighting cells (CD8+ T cells) to attack the tumor and potentially stop tumors from growing.
In this study, researchers want to learn if TAK-188 can help the body's immune system better fight cancer in adults with advanced cancers which have not gotten better with regu...